AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Chemomab Therapeutics Ltd. Director's Dealing 2021

Mar 25, 2021

35107_dirs_2021-03-25_73573080-d7bf-4e19-86cd-906b1f5f001f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Chemomab Therapeutics Ltd. (CMMB)
CIK: 0001534248
Period of Report: 2021-03-16

Reporting Person: Darvish Nissim (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option to purchase American Depositary Shares	$0.80	2026-10-27	American Depositary Shares (10123)		Direct

Footnotes

F1: The options reported in this row have all vested and are exercisable as of the date hereof, subject to the Reporting Person's continued service.

F2: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.